Manulife (Manufacturers Life Insurance)’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.4M Sell
77,580
-8,488
-10% -$2.12M 0.02% 649
2025
Q4
$20.7M Buy
86,068
+1,644
+2% +$420K 0.02% 631
2025
Q3
$23.1M Buy
84,424
+180
+0.2% +$49.2K 0.02% 603
2025
Q2
$21.7M Sell
84,244
-3,066
-4% -$731K 0.02% 589
2025
Q1
$19.5M Sell
87,310
-579
-0.7% -$135K 0.02% 608
2024
Q4
$20.1M Sell
87,889
-580
-0.7% -$140K 0.02% 622
2024
Q3
$21.6M Buy
88,469
+240
+0.3% +$53.6K 0.02% 616
2024
Q2
$16.9M Sell
88,229
-591
-0.7% -$120K 0.02% 659
2024
Q1
$17.6M Sell
88,820
-9,275
-9% -$1.7M 0.02% 662
2023
Q4
$16.9M Sell
98,095
-2,147
-2% -$330K 0.01% 674
2023
Q3
$14.8M Sell
100,242
-1,092
-1% -$197K 0.01% 668
2023
Q2
$22.1M Sell
101,334
-2,278
-2% -$508K 0.01% 566
2023
Q1
$22.7M Sell
103,612
-4,397
-4% -$954K 0.01% 569
2022
Q4
$22.5M Sell
108,009
-1,766
-2% -$388K 0.01% 555
2022
Q3
$24M Buy
109,775
+3,076
+3% +$700K 0.02% 523
2022
Q2
$22.4M Sell
106,699
-5,402
-5% -$1.15M 0.02% 570
2022
Q1
$27.2M Buy
112,101
+1,362
+1% +$329K 0.02% 561
2021
Q4
$28.8K Sell
110,739
-24,887
-18% -$6.46M 0.02% 525
2021
Q3
$35.7M Sell
135,626
-5,274
-4% -$1.44M 0.03% 458
2021
Q2
$34.7M Sell
140,900
-2,073
-1% -$436K 0.03% 470
2021
Q1
$27.7M Buy
142,973
+1,232
+0.9% +$247K 0.02% 524
2020
Q4
$30.1M Sell
141,741
-11,183
-7% -$2.23M 0.03% 481
2020
Q3
$26.2M Sell
152,924
-39,764
-21% -$7.34M 0.03% 466
2020
Q2
$36.3M Buy
192,688
+31,659
+20% +$5.18M 0.03% 378
2020
Q1
$23.7M Buy
161,029
+26,135
+19% +$4.16M 0.03% 433
2019
Q4
$20.9M Sell
134,894
-7,422
-5% -$1.07M 0.02% 544
2019
Q3
$19M Buy
142,316
+10,716
+8% +$1.4M 0.02% 569
2019
Q2
$16.1M Sell
131,600
-10,502
-7% -$1.16M 0.02% 634
2019
Q1
$14.8M Buy
142,102
+1,415
+1% +$146K 0.02% 660
2018
Q4
$16M Sell
140,687
-3,288
-2% -$352K 0.02% 570
2018
Q3
$16.6M Sell
143,975
-21,134
-13% -$2.31M 0.02% 643
2018
Q2
$17.1M Buy
165,109
+12,034
+8% +$1.22M 0.02% 643
2018
Q1
$15.1M Sell
153,075
-2,729
-2% -$258K 0.02% 682
2017
Q4
$13.2M Buy
155,804
+1,942
+1% +$160K 0.01% 731
2017
Q3
$11.8M Sell
153,862
-55,160
-26% -$4.22M 0.01% 738
2017
Q2
$16.3M Buy
209,022
+3,728
+2% +$267K 0.02% 621
2017
Q1
$14.8M Buy
205,294
+12,416
+6% +$858K 0.02% 647
2016
Q4
$12M Sell
192,878
-716
-0.4% -$43.9K 0.02% 649
2016
Q3
$12.5M Buy
193,594
+2,935
+2% +$195K 0.02% 610
2016
Q2
$12.1M Buy
190,659
+4,893
+3% +$288K 0.02% 600
2016
Q1
$10.6M Buy
185,766
+3,137
+2% +$178K 0.01% 645
2015
Q4
$9.8K Sell
182,629
-1,228
-0.7% -$69.2K 0.01% 671
2015
Q3
$9.37K Sell
183,857
-4,658
-2% -$251K 0.01% 694
2015
Q2
$10.6K Buy
188,515
+6,158
+3% +$389K 0.01% 672
2015
Q1
$13.1K Buy
182,357
+3,229
+2% +$210K 0.02% 575
2014
Q4
$10K Sell
179,128
-6,462
-3% -$337K 0.01% 640
2014
Q3
$9.14K Buy
185,590
+4,232
+2% +$216K 0.01% 669
2014
Q2
$9.18M Buy
181,358
+102,028
+129% +$5.06M 0.01% 675
2014
Q1
$9.33K Sell
79,330
-131,622
-62% -$5.91M 0.01% 692
2013
Q4
$9.93K Buy
210,952
+28,353
+16% +$1.44M 0.02% 662
2013
Q3
$9.65K Buy
182,599
+3,095
+2% +$150K 0.02% 649
2013
Q2
$8.1M Buy
+179,504
New +$8.52M 0.02% 641

Other funds holding RMD

Manulife (Manufacturers Life Insurance)'s RMD Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its ResMed (RMD) stake by 9.9% in Q1 2026, selling an estimated $2.12M and leaving 77,580 shares worth $17.4M. The position accounts for 0.02% of the portfolio, ranked #649.

Manulife (Manufacturers Life Insurance) first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $36.3M in Q2 2020. 940 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 77,580 shares of ResMed worth $17.4M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 8,488 ResMed shares in Q1 2026, an estimated $2.12M.
  • ResMed made up 0.02% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #649 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
  • Manulife (Manufacturers Life Insurance)'s ResMed position peaked at $36.3M in Q2 2020.
  • 940 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.